GGHSX Holdings — Invesco Health Care Fund
All 82 reported holdings of Invesco Health Care Fund (GGHSX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly and Co. | 10.59% | $127.89M |
| Johnson & Johnson | 6.76% | $81.64M |
| UnitedHealth Group Inc. | 6.17% | $74.44M |
| Invesco Private Prime Fund | 4.67% | $56.33M |
| Merck & Co., Inc. | 4.59% | $55.42M |
| AbbVie Inc. | 4.03% | $48.60M |
| Gilead Sciences, Inc. | 3.63% | $43.88M |
| argenx SE | 3.24% | $39.08M |
| CVS Health Corp. | 2.52% | $30.42M |
| Welltower Inc. | 2.34% | $28.24M |
| BrightSpring Health Services, Inc. | 2.20% | $26.55M |
| Royalty Pharma PLC | 2.13% | $25.77M |
| Cardinal Health, Inc. | 2.10% | $25.34M |
| Guardant Health, Inc. | 2.04% | $24.65M |
| Vertex Pharmaceuticals Inc. | 2.01% | $24.31M |
| Invesco Private Government Fund | 1.80% | $21.70M |
| Axsome Therapeutics, Inc. | 1.58% | $19.12M |
| Edwards Lifesciences Corp. | 1.56% | $18.86M |
| Invesco Treasury Portfolio | 1.56% | $18.83M |
| Thermo Fisher Scientific Inc. | 1.55% | $18.74M |
| BridgeBio Pharma, Inc. | 1.43% | $17.32M |
| Waters Corp. | 1.41% | $17.04M |
| IQVIA Holdings Inc. | 1.32% | $15.93M |
| U C B S.a. | 1.24% | $14.95M |
| Ligand Pharmaceuticals Inc. | 1.18% | $14.21M |
| Protagonist Therapeutics, Inc. | 1.18% | $14.20M |
| Natera, Inc. | 1.17% | $14.10M |
| Sandoz Group AG | 1.14% | $13.79M |
| Ascendis Pharma A/S | 1.09% | $13.20M |
| Revolution Medicines, Inc. | 1.09% | $13.10M |
| Amgen Inc. | 1.07% | $12.87M |
| Halozyme Therapeutics, Inc. | 1.06% | $12.80M |
| United Therapeutics Corp. | 0.99% | $11.93M |
| Quest Diagnostics Inc. | 0.98% | $11.87M |
| Mettler-Toledo International Inc. | 0.92% | $11.11M |
| Charles River Laboratories International, Inc. | 0.92% | $11.05M |
| Intuitive Surgical, Inc. | 0.90% | $10.84M |
| Galderma Group AG | 0.90% | $10.82M |
| Medline Inc. | 0.86% | $10.40M |
| Madrigal Pharmaceuticals, Inc. | 0.82% | $9.89M |
| Invesco Government & Agency Portfolio | 0.81% | $9.78M |
| AstraZeneca PLC | 0.79% | $9.53M |
| West Pharmaceutical Services, Inc. | 0.79% | $9.52M |
| Labcorp Holdings Inc. | 0.71% | $8.59M |
| Lonza Group AG | 0.71% | $8.52M |
| Cytokinetics, Inc. | 0.69% | $8.32M |
| Tenet Healthcare Corp. | 0.67% | $8.03M |
| Steris PLC | 0.63% | $7.56M |
| Krystal Biotech, Inc. | 0.57% | $6.94M |
| Arrowhead Pharmaceuticals, Inc. | 0.57% | $6.93M |
| Globus Medical, Inc. | 0.57% | $6.90M |
| Twist Bioscience Corp. | 0.57% | $6.84M |
| Medpace Holdings, Inc. | 0.56% | $6.81M |
| Encompass Health Corp. | 0.49% | $5.94M |
| Alignment Healthcare, Inc. | 0.47% | $5.71M |
| Rhythm Pharmaceuticals, Inc. | 0.47% | $5.66M |
| Humana Inc. | 0.45% | $5.47M |
| Praxis Precision Medicines, Inc. | 0.42% | $5.10M |
| Teva Pharmaceutical Industries Ltd. | 0.42% | $5.06M |
| Cogent Biosciences, Inc. | 0.40% | $4.83M |
| Mirum Pharmaceuticals, Inc. | 0.40% | $4.77M |
| BioLife Solutions, Inc. | 0.39% | $4.74M |
| BillionToOne, Inc. | 0.39% | $4.66M |
| Rapport Therapeutics, Inc. | 0.37% | $4.51M |
| LeMaitre Vascular, Inc. | 0.37% | $4.46M |
| Centene Corp. | 0.34% | $4.04M |
| RadNet, Inc. | 0.33% | $4.00M |
| IDEXX Laboratories, Inc. | 0.32% | $3.88M |
| Glaukos Corp. | 0.31% | $3.76M |
| Dianthus Therapeutics, Inc. | 0.30% | $3.59M |
| Xenon Pharmaceuticals Inc. | 0.27% | $3.30M |
| Bruker Corp. | 0.26% | $3.18M |
| Heartflow, Inc. | 0.25% | $3.06M |
| Tarsus Pharmaceuticals, Inc. | 0.25% | $2.98M |
| Palvella Therapeutics, Inc. | 0.24% | $2.89M |
| Incyte Corp. | 0.22% | $2.69M |
| uniQure N.V. | 0.19% | $2.30M |
| Edgewise Therapeutics, Inc. | 0.14% | $1.70M |
| Kiniksa Pharmaceuticals International, PLC | 0.14% | $1.68M |
| Phathom Pharmaceuticals, Inc. | 0.13% | $1.62M |
| GMR Solutions Inc. | 0.13% | $1.56M |
| Mineralys Therapeutics, Inc. | 0.12% | $1.44M |
GGHSX overview: performance, fees, allocation and SEC filings